copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Modified Nucleic Acid Custom mRNA Experts | TriLink BioTechnologies TriLink has been an industry leader in synthesizing high quality oligonucleotides for research, diagnostics, therapeutics, and OEM for more than 20 years We offer a wide selection of DNA, RNA, modified, and specialty oligonucleotides in scales up to multiple grams
About us - TriLink BioTechnologies TriLink BioTechnologies, part of Maravai LifeSciences, is a best-in-class contract development and manufacturing organization (CDMO) for the synthesis of nucleic acids, NTPs and mRNA capping analogs
Contact Us | TriLink BioTechnologies Please keep me informed about updates from TriLink Biotechnologies, including webinars, new product releases, and upcoming events Please note the minimum starting synthesis scale we can offer for 4 or less sequences is 5 0 µmole and 1 µmole for 5 or more sequences What gene editing systems are you using or plan to use? Select all that apply
CleanCap mRNA Capping Technology | TriLink BioTechnologies TriLink offers a robust portfolio of patented CleanCap ® cap analogs for use in the discovery or GMP manufacturing of vaccines, cell therapies, gene replacement therapies, and more, ensuring an optimal mRNA capping strategy to help maximize mRNA potency and subsequent protein expression
mRNA CDMO Services | TriLink BioTechnologies Leverage a legacy of trailblazing innovation in your mRNA research and discovery with TriLink Our dedicated staff has specialized mRNA expertise to support your journey, helping you make discoveries, scale up production, overcome regulatory challenges, and get to market faster
CleanCap® Reagent AG | TriLink Customer Portal CleanCap® Reagent AG is TriLink's patented co-transcriptional capping reagent for in vitro transcription of 5' capped mRNA resulting in a Cap 1 structure CleanCap has shown to provide up to 98% capping efficiency
mRNAbuilder tool | TriLink BioTechnologies TriLink has a legacy of trailblazing innovation in mRNA synthesis Now, with the mRNAbuilder® tool, you can leverage our up-leveled sequence design platform and order your construct online